Immunogen | Capitale Ordinario

Ordinary Share Capital Cambiamento Data
Agios Pharmaceuticals USD 72K 0 2023-12
Amgen USD 32.75B 152M 2023-09
AstraZeneca USD 387M 0 2023-09
Eli Lilly USD 593.6M 0 2023-09
Exelixis USD 311K 9K 2023-09
Halozyme Therapeutics USD 127K 5K 2023-12
Pfizer USD 478M 0 2023-09
Regeneron Pharmaceuticals USD 102K 0 2023-09
Roche Holding CHF 107M 0 2023-06



Immunogen Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.